1416356-21-2

Basic information

• Product Name: (E)-3,5,4'-tri[(N-benzylpiperazine-N'-carbonyl)oxy]stilbene
• Synonyms: (E)-3,5,4'-tri[(N-benzylpiperazine-N'-carbonyl)oxy]stilbene
• CAS NO: 1416356-21-2
• Molecular Weight: 835.015
• Mol File: 1416356-21-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-3,5,4'-tri[(N-benzylpiperazine-N'-carbonyl)oxy]stilbene(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3,5,4'-tri[(N-benzylpiperazine-N'-carbonyl)oxy]stilbene(1416356-21-2)
• EPA Substance Registry System: (E)-3,5,4'-tri[(N-benzylpiperazine-N'-carbonyl)oxy]stilbene(1416356-21-2)

Safety Data

• Hazardous Substances Data: 1416356-21-2(Hazardous Substances Data)

Upstream product

• 63763-66-6 4-(phenylmethyl)-1-piperazine carbonyl chloride 
• 501-36-0 (E)-5-[2-4-(hydroxyphenyl)ethenyl]-1,3-benzenediol 

Relevant articles and documents

Synthesis of pterostilbene and resveratrol carbamate derivatives as potential dual cholinesterase inhibitors and neuroprotective agents

Pterostilbene and resveratrol carbamate derivatives were designed and synthesized by use of a multi-target directed drug-design strategy. Their acetylcholinesterase and butylcholinesterase inhibitory activity and neuroprotective effects against hydrogen peroxide-induced PC12 cell injury were evaluated in vitro. The results indicated that some of the compounds had dual inhibitory potency against acetylcholinesterase and butylcholinesterase, and potential neuroprotective effects, and could be considered as potential multi-target-directed agents.